Numazawa Mitsuteru, Nagaoka Masao, Sohtome Norishige
Tohoku Pharmaceutical University, 4-1 Komatsushima-4-chome, Aobaku, Sendai 981-8558, Japan.
Biochemistry. 2005 Aug 16;44(32):10839-45. doi: 10.1021/bi0508744.
Aromatase is a cytochrome P-450 enzyme complex that catalyzes the conversion of androst-4-ene-3,17-dione (AD) to estrone and formic acid through three sequential oxygenations of the 19-methyl group. To gain insight into the catalytic function of aromatase as well as the mechanism of the hitherto uncertain third oxygenation step, we focused on the aromatase-catalyzed 19-oxygenation of 3-deoxyandrogens: 3-deoxy-AD (1), which is a very powerful competitive inhibitor but poor substrate of aromatase, and its 5-ene isomer 4, which is a good competitive inhibitor and effective substrate of the enzyme. In incubations of their 19S-(3)H-labeled 19-hydroxy derivatives 2 and 5 and the corresponding 19R-(3)H isomers with human placental microsomes in the presence of NADPH under air, the radioactivity was liberated in both water and formic acid. The productions of (3)H(2)O and (3)HCOOH were blocked by the substrate AD or the inhibitor 4-hydroxy-AD, indicating that these productions are due to a catalytic function of aromatase. A comparison of the (3)H(2)O production from S-(3)H substrates 2 and 5 with that from the corresponding R-(3)H isomers revealed that the 19-pro-R hydrogen atom was stereospecifically (pro-R:pro-S = 100:0) removed in the conversion of 5-ene substrate 5 into the 19-oxo product 6, whereas 75:25 stereoselectivity for the loss of the pro-R and pro-S hydrogen atoms was observed in the oxygenation of the other substrate, 2. The present results reveal that human placental aromatase catalyzes three sequential oxygenations at C-19 of 3-deoxyandrogens 1 and 4 to cause the cleavage of the C(10)-C(19) bond through their 19-hydroxy (2 and 5) and 19-oxo (3 and 6) intermediates, respectively, where there is a difference in the stereochemistry between the two androgens in the second 19-hydroxylation. It is implied that the aromatase-catalyzed 19-oxygenation of 5-ene steroid 4 but not the 4-ene isomer 1 would proceed in the same steric mechanism as that involved in the AD aromatization.
芳香化酶是一种细胞色素P-450酶复合物,它通过对19-甲基进行三步连续的氧化反应,催化雄甾-4-烯-3,17-二酮(AD)转化为雌酮和甲酸。为了深入了解芳香化酶的催化功能以及迄今尚不确定的第三步氧化反应的机制,我们重点研究了芳香化酶催化的3-脱氧雄激素的19-氧化反应:3-脱氧-AD(1),它是一种非常强效的竞争性抑制剂,但却是芳香化酶的不良底物,及其5-烯异构体4,它是一种良好的竞争性抑制剂且是该酶的有效底物。在空气存在下,于NADPH存在的条件下,将其19S-(3)H标记的19-羟基衍生物2和5以及相应的19R-(3)H异构体与人胎盘微粒体一起孵育时,放射性物质在水和甲酸中均有释放。(3)H(2)O和(3)HCOOH的生成被底物AD或抑制剂4-羟基-AD阻断,表明这些生成是由于芳香化酶的催化功能所致。比较S-(3)H底物2和5与相应的R-(3)H异构体的(3)H(2)O生成情况发现,在5-烯底物5转化为19-氧代产物6的过程中,19-前-R氢原子被立体特异性地(前-R:前-S = 100:0)去除,而在另一种底物2的氧化反应中,观察到前-R和前-S氢原子损失的立体选择性为75:25。目前的结果表明,人胎盘芳香化酶催化3-脱氧雄激素1和4的C-19位进行三步连续的氧化反应,分别通过其19-羟基(2和5)和19-氧代(3和6)中间体导致C(10)-C(19)键的断裂,其中两种雄激素在第二次19-羟基化反应中的立体化学存在差异。这意味着芳香化酶催化的5-烯甾体4而非4-烯异构体1的19-氧化反应将以与AD芳香化反应相同的空间机制进行。